The performance of nicotinic acid in shifting myocardial metabolism to glucose in 18F-labeled 2-deoxyglucose (FDG) PET-CT myocardial viability assessment

被引：0
|
作者：
Nordin, A. [1 ]
Saad, F. Ahmad [1 ]
Aziz, A. Abdul [1 ]
Azman, A. [1 ]
Azliza, W. [2 ]
Ahmad, W. Wan [2 ]
机构：
[1] Univ Putra Malaysia, Serdang, Malaysia
[2] Univ Malaya, Kuala Lumpur, Malaysia
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2012年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P0377
引用
收藏
页码：S427 / S427
页数：1
相关论文
共 50 条
  • [1] Myocardial viability assessment in 18FDG PET/CT study (18FDG PET myocardial viability assessment)
    Kobylecka, Malgorzata
    Maczewska, Joanna
    Fronczewska-Wieniawska, Katarzyna
    Mazurek, Tomasz
    Plazinska, Maria Teresa
    Krolicki, Leszek
    NUCLEAR MEDICINE REVIEW, 2012, 15 (01) : 52 - 60
  • [2] Multimodality imaging PET-CT using 18F-labeled 2-deoxyglucose (FDG) ensures effective treatment delivery by improving the staging of head and neck malignancy
    Nordin, A.
    Saad, F. Ahmad
    Yusof, M. Md
    Subha, S.
    Abu Bakar, S.
    Rahim, N. Abdul
    Rossetti, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S398 - S398
  • [3] Experience in starting a service for myocardial viability PET-CT using 18FDG
    Mayes, C.
    Barrett, P.
    Hufton, I.
    Seshadri, N.
    Sreedasyam, A.
    Vinjamuri, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S137 - S137
  • [4] 18F-FDG PET and Myocardial Viability Assessment: Trials and Tribulations
    Allman, Kevin C.
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (04) : 505 - 506
  • [5] 18F-FDG PET/CT for the Assessment of Myocardial Sarcoidosis
    Skali, Hicham
    Schulman, Allison R.
    Dorbala, Sharmila
    CURRENT CARDIOLOGY REPORTS, 2013, 15 (04)
  • [6] 18F-FDG PET/CT for the Assessment of Myocardial Sarcoidosis
    Hicham Skali
    Allison R. Schulman
    Sharmila Dorbala
    Current Cardiology Reports, 2013, 15
  • [7] Myocardial glucose metabolism in patients with hypertrophic cardiomyopathy: Assessment by F-18-FDG PET study
    Uehara T.
    Ishida Y.
    Hayashida K.
    Shimonagata T.
    Miyake Y.
    Sago M.
    Oka H.
    Nagata S.
    Miyatake K.
    Nishimura T.
    Annals of Nuclear Medicine, 1998, 12 (2) : 95 - 103
  • [8] Myocardial viability assessment using 18F FDG gated PET.
    Inubushi, M
    Ishida, Y
    Fukuchi, K
    Fukushima, K
    Sasako, K
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 157P - 157P
  • [9] Comparison of multidetector CT with F-18-FDG-PET and SPECT in the assessment of myocardial viability in patients with myocardial infarction: A preliminary study
    Lee, In Ho
    Choe, Yeon Hyeon
    Lee, Kyung Han
    Jeon, Eun-Seok
    Choi, Jin-Ho
    EUROPEAN JOURNAL OF RADIOLOGY, 2009, 72 (03) : 401 - 405
  • [10] Use of unfractionated heparin for the suppression of myocardial glucose metabolism in 18F-FDG PET/CT studies
    Suarez Fernandez, J. P.
    Gonzalez Garcia, F. M.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2021, 40 (01): : 67 - 68
12345